Quimifar
Quimifar is a Panamanian pharmaceutical distributor founded in 1966 that represents North American and European pharmaceutical labs, distributing prescription drugs, diagnostics, and surgical materials to pharmacies, hospitals, and clinics across Panama via a national 13-van fleet.
- Company typePrivate
- Founded1966
- HeadquartersPaitilla, Panama
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Quimifar does
Quimifar, S.A. is a Panamanian pharmaceutical distribution company founded on September 1, 1966, headquartered in Panama City (Paitilla area). The company acts as a representative and distributor for prestigious pharmaceutical laboratories primarily from North America and Europe, importing and distributing pharmaceutical products, clinical diagnostic chemical reagents, electronic diagnostic equipment, and surgical materials across Panama. In 1994, Quimifar acquired Agencias Tomás Arias, S.A., expanding its portfolio of represented pharmaceutical houses. The company's offerings are organized under two sub-brands: TERAPÉUTICA (therapeutic/medical products) and POPULAR (consumer-oriented pharmaceutical products).
The company's business model is built on a sales-led, field-distribution approach. An 11-50 employee organization operates a multi-tier sales team — including a Gerente de Ventas y Mercadeo, Visitadores Médicos, Promotores de Ventas, Coordinadoras de Ventas, Vendedores a Nivel Nacional, Cotizadores Institucionales, and Supervisores de Campos — with field coverage in Chiriquí Province, Central Provinces, and Colón. National distribution is executed through a fleet of 13 modern vans, including a night-delivery capability that is a stated differentiator. Pricing is quote-based and negotiated per-transaction with institutional customers, with no public pricing disclosed.
Quimifar serves pharmacies, hospitals, clinics, and healthcare institutions across Panama, addressing the need for reliable supply chain access to international pharmaceutical brands at accessible prices. The company is privately held with no parent company, no disclosed institutional investors, and no funding rounds on record. Operating geographies are explicitly limited to Panama, with no global footprint claim. No AI/ML capabilities, proprietary technology platforms, or digital ordering channels are documented; the technology base is described as pharmaceutical distribution and supply chain management.
Quimifar firmographics
Firmographics- Name
- Quimifar
- Legal name
- Quimifar, S.A.
- Website
- https://quimifar.com
- Company type
- Private
- Founded year
- 1966
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Quimifar is a Panamanian pharmaceutical distributor founded in 1966 that represents North American and European pharmaceutical labs, distributing prescription drugs, diagnostics, and surgical materials to pharmacies, hospitals, and clinics across Panama via a national 13-van fleet.
- Ownership category
- akta.pro rank
Quimifar industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where Quimifar is headquartered
LocationHeadquarters
- HQ city
- Paitilla
- HQ country
- Panama
- HQ region
- Latin America
Offices1 record
Markets served
Quimifar business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Distribution: Distribution and representation of pharmaceutical products from prestigious North American and European laboratories, importing and distributing pharmaceutical products, clinical diagnostic chemical reagents, electronic diagnostic equipment, and surgical materials in Panama.
Go-to-market motion1 record
Distribution channels2 records
Quimifar product offering
Product offeringCore offering
Quimifar imports and distributes pharmaceutical products from prestigious North American and European laboratories across Panama, supplying pharmacies, hospitals, and clinics. The company also distributes clinical diagnostic chemical reagents, electronic diagnostic equipment, and surgical materials via a national fleet of 13 modern vans with night delivery capability.
Product overview
Quimifar is a pharmaceutical distribution company that operates as a unified distribution platform representing and distributing products from prestigious pharmaceutical laboratories, primarily from North America and Europe. The company offers two main product sub-brands: TERAPÉUTICA for therapeutic/medical products and POPULAR for consumer-oriented pharmaceutical products. The company also distributes clinical diagnostic reagents, electronic diagnostic equipment, and surgical materials. Distribution is handled nationwide through a fleet of 13 modern vans, supported by a dedicated sales team including medical representatives, sales promoters, coordinators, and institutional sales staff.
Differentiator
Problem solved
Functional benefit
Brands
- TERAPÉUTICA: Pharmaceutical therapeutic products brand
- POPULAR
Products and services
- TERAPÉUTICA Pharmaceutical therapeutic products brand representing prestigious pharmaceutical laboratories, offering pharmaceutical products for medical treatment to pharmacies, hospitals, and clinics in Panama.
- POPULAR Popular consumer pharmaceutical brand representing renowned pharmaceutical companies and laboratories, providing accessible pharmaceutical products to retail pharmacies and consumers in the Panamanian market.
- Clinical Diagnostic Reagents Chemical reagents for clinical diagnostic use, distributed to hospitals, clinics, and diagnostic laboratories across Panama.
- Electronic Diagnostic Equipment Electronic diagnostic devices distributed to healthcare institutions and clinical facilities in Panama for medical diagnostic purposes.
- Surgical Materials Surgical materials distributed to hospitals and surgical centers in Panama for medical and surgical procedures.
Companies that use Quimifar
Customer profileSegments1 record
Ideal customer profiles1 record
Quimifar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Quimifar partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AGENCIAS TOMÁS ARIAS, S.A.corePanamanian company acquired in 1994, bringing prestigious pharmaceutical laboratory representations. This acquisition expanded Quimifar's portfolio of represented pharmaceutical houses.
Scale indicators3 records
Recent moves4 records
Expansion highlights4 records
Quimifar competitors and assessment
Company assessmentBroad incumbents
- McKesson Corporation: Global pharmaceutical distributor and healthcare services company. Comparable as a wholesale pharma distribution incumbent with operations across the Americas, though at vastly greater scale than Quimifar and focused on the broader North American and European markets.
- Cardinal Health: U.S.-headquartered global wholesale distributor of pharmaceuticals and medical products to retail, hospital, and institutional customers. Highly comparable wholesale pharma distribution function, though at materially larger scale and geographic breadth than Quimifar.
- Bayer: Global pharmaceutical and consumer health company and one of the types of 'prestigious North American and European pharmaceutical houses' Quimifar distributes for. Comparable as an upstream principal that uses local distributors like Quimifar to access Latin American markets, illustrating both the supplier side and the broader pharma value chain Quimifar participates in.
- Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distributors, providing drug distribution and related services to pharmacies, hospitals, and healthcare providers worldwide. Overlaps with Quimifar's distribution role but operates as a global broad incumbent rather than a regional specialist.
Regional players
- Sigma Pharmaceuticals: Latin American-focused pharmaceutical distribution and retail operator with strong presence in Mexico and other regional markets. Comparable business model as a regional pharma distributor serving pharmacies and institutional buyers, though concentrated in Mexico rather than Central America.
Direct peers
- Grupo IFA: One of the largest pharmaceutical distribution and retail pharmacy groups in Panama, with broad national coverage of retail pharmacies, drugstores, and distribution operations — directly competing with Quimifar for institutional customers and pharma principal mandates.
- Casa de la Salud: Panamanian pharmaceutical distributor and pharmacy chain that combines wholesale distribution with retail pharmacy operations. Comparable to Quimifar in customer base (institutional + retail) and in offering a vertically integrated pharma supply model in Panama.
- Cefa S.A. Established Panamanian pharmaceutical distributor and pharmacy operator. Directly comparable to Quimifar as a Panama-headquartered pharma distribution platform supplying pharmacies, hospitals, and clinics with branded and generic medications.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Quimifar social profiles
Digital presenceQuimifar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quimifar leadership team
Management profileNumber of profiles
Quimifar subsidiaries and ownership
Company hierarchySubsidiaries1 record
Quimifar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quimifar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quimifar
What does Quimifar do?
Quimifar imports and distributes pharmaceutical products from prestigious North American and European laboratories across Panama, supplying pharmacies, hospitals, and clinics. The company also distributes clinical diagnostic chemical reagents, electronic diagnostic equipment, and surgical materials via a national fleet of 13 modern vans with night delivery capability.
Is Quimifar a public or private company?
Quimifar is a private company. It is classified as unknown and is currently operating.
When was Quimifar founded?
Quimifar was founded in 1966. It employs 11 to 50 people.
Where is Quimifar based?
Quimifar is headquartered in Paitilla, Panama, in the Latin America region.
How does Quimifar make money?
One revenue line is on record: pharmaceutical Distribution.
Who are Quimifar's main competitors?
Broad incumbents on record are McKesson Corporation, Cardinal Health, Bayer and Cencora (formerly AmerisourceBergen). Sigma Pharmaceuticals is listed as a regional player. Direct peers are Grupo IFA, Casa de la Salud and Cefa S.A..
Does Quimifar have an API?
No public API is recorded for Quimifar.
What industry is Quimifar in?
Quimifar's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 42421 and its SIC code is 5122.